Fungal infections are a major contributor to infectious disease-related deaths across the
globe. Candida species are among the most common causes of invasive mycotic disease …

Fungal infections, named mycosis, can cause severe invasive and systemic diseases that
can even lead to death. In recent years, epidemiological data have recorded an increase in …

Annually, over 150 million severe cases of fungal infections occur worldwide, resulting in
approximately 1.7 million deaths per year. Alarmingly, these numbers are continuously on …

Fungi are an understudied resource possessing huge potential for developing products that
can greatly improve human well-being. In the current paper, we highlight some important …

The treatment of invasive fungal infections remains challenging due to limitations in currently
available antifungal therapies including toxicity, interactions, restricted routes of …

Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular
those with haematological malignancies undergoing remission-induction chemotherapy for …

The current rise in invasive fungal infections due to the increase in immunosuppressive
therapies is a real concern. Moreover, the emergence of resistant strains induces …

Background A better understanding of the epidemiology and clinical features of invasive
fungal infection (IFI) is integral to improving outcomes. We describe a novel case-finding …

Amphotericin B (AmB), a broad-spectrum polyene antibiotic in the clinic for more than fifty
years, remains the gold standard in the treatment of life-threatening invasive fungal …

Azole antifungals are first-line options in the prophylaxis and treatment of invasive fungal
infections. They are often used for prolonged (weeks to months) periods of time, particularly …